Navigation Links
EXAMINE-Studie zur kardiovaskulären Sicherheit von Alogliptin erreicht primären Endpunkt: keine Erhöhung des kardiovaskulären Risikos bei Risikopatienten mit Typ-2 Diabetes
Date:9/11/2013

sgemäß den Behörden mitgeteilt.

Informationen zu Diabetes Typ 2
Diabetes Typ 2 ist die häufigste Form von Diabetes, unter der Millionen Menschen weltweit leiden. Diabetes Typ 2 ist eine fortschreitende und chronische Erkrankung; Patienten sollten ihre Erkrankung regelmäßig von einem Arzt kontrollieren lassen. Neben Diät und Bewegung müssen die Patienten häufig ein oder mehrere Medikamente einnehmen, um ihren Blutzuckerspiegel unter Kontrolle zu halten. Der „International Diabetes Federation" zufolge beliefen sich die Gesundheitsausgaben für Diabetes (Typ 1 und 2) im Jahr 2012 auf mehr als 471 Milliarden USD. Es wird geschätzt, dass dieser Betrag bis 2030 595 Milliarden USD überschreiten wird.

Informationen zu Alogliptin
Alogliptin ist ein Dipeptidylpeptidase-4-Inhibitor (DPP-4i) zur Behandlung von Diabetes Typ 2 bei Erwachsenen, in Ergänzung zu Diät und Bewegung. DPP-4is verlangsamen die Deaktivierung der Incretin-Hormone GLP-1 und GIP. Durch eine erhöhte Menge an aktiven Inkretinen kann die Bauchspeicheldrüse Insulin Glukose-abhängig sezernieren und so die Kontrolle des Blutzuckerspiegels unterstützen. Das japanische Ministerium für Gesundheit, Arbeit und Wohlfahrt ließ im April 2010 eine New Drug Application (NDA) für NESINA (Alogliptin) zur Behandlung von Diabetes Typ 2 zu; das Medikament ist in Japan unter eben diesem Markennamen erhältlich. NESINA (Alogliptin) wurde von der US-amerikanischen FDA im Januar 2013 sowohl als  Monotherapie als auch als Kombinationstherapie  (fixed-dose combination, FDC) mit Pioglitazon (OSENI) und Metformin (KAZANO) für die Behandlung von Diabetes Typ 2 bei Erwachsenen als Ergänzung zu Diät und Bewegung zugelassen. Alogliptin als Monopräparat ist gegenwärtig in Tablettendosierungen zu 6,25 mg,
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. American College of Chest Physicians (ACCP) und Simbionix arbeiten zusammen, um klinische Ausbildung und Patientensicherheit zu verbessern
2. Messe/Konferenz InnoPack Pharma legt den Fokus auf innovative Verpackungen für Compliance und Sicherheit
3. Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
4. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
5. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
6. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
7. National Diabetes Volunteer Leadership Council (NDVLC) Urges FDA to Enforce Stringent Accuracy Standards for Blood Glucose Monitoring Systems
8. Clinilabs Sponsors The ADAs 2013 Step Out: Walk to Stop Diabetes
9. GSMA mHealth Grand Tour Highlights How Mobile Technology Could Help Prevent 5 Million People In The EU From Developing Diabetes
10. Elcelyx Therapeutics NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study
11. Bio-Solutions Corp. Expanding in Booming Diabetes Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... According to Kalorama Information, electronic medical records ... Data in healthcare a reality, and this a factor ... American Recovery and Reinvestment Act, the U.S. government dedicated ... penalties will start applying soon for use of paper ... study of the EMR industry, EMR 2014: The ...
(Date:8/19/2014)...  SCILEX Pharmaceuticals, Inc., a company engaged in the ... treatment of pain, announced that it had formed a Scientific ... Gudin , Dr. Charles Argoff , Dr. ... SCILEX Chief Executive Officer Anthony ... greatly assist in the development and commercialization of future ...
(Date:8/19/2014)... -- Sequence, Inc., an industry leader in the field of quality ... is opening a third office location in the "Gateway to ... result of demand by clients to provide cost effective solutions ... Sequence to better serve new and existing customers in the ... office provides Sequence a hub to support customers in ...
Breaking Medicine Technology:Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3SCILEX Pharmaceuticals Announces Scientific Advisory Board 2SCILEX Pharmaceuticals Announces Scientific Advisory Board 3SCILEX Pharmaceuticals Announces Scientific Advisory Board 4Quality and Compliance Solutions Provider Announces Opening of St. Louis, Missouri Office 2
... 2011 Assured Pharmacy (Pink Sheets: APHY ), ... than 3,000 sufferers of chronic pain announced that total sales ... 2010 were $1,514,984 which equates to $70,464 per business day. ... total sales of $1,348,344 for December 2009 which equates to ...
... 2011 BioDelivery Sciences International, Inc. ... outcome of a pre-Investigational New Drug (pre-IND) meeting ... on the development program for BEMA Buprenorphine/Naloxone, BDSI,s ... discussed is based on pharmacokinetic and safety data ...
Cached Medicine Technology:Assured Pharmacy Reports Same Store Sales for the Month of December 2010 2Assured Pharmacy Reports Same Store Sales for the Month of December 2010 3BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting 2BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting 3
(Date:8/20/2014)... Verndale is pleased to announce their recent ... list ranking the fastest-growing private companies in America. The ... yearly percentage revenue growth over a three-year period. For ... 5000 list where it ranked number 2,855. , As ... a wide range of digital marketing services including core ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Oxnard ... founder of the Anacapa Dental Art Institute, is presenting ... Dr. Jivraj will be speaking on All-on-4 dental ... Aspects of Graft Less Solutions” at 12:40 p.m. Sept. ... in Vancouver, British Columbia, Canada. , “The All-on-4 procedure ...
(Date:8/20/2014)... No matter how “lonely” a person may be, ... of friends to be always there for them. However, it ... of making new friends during adulthood : not only ... care of one’s family to a near-slavish devotion to career-building, ... person just is not the same as it was when ...
(Date:8/20/2014)... BuyCheapTicketsToEvents.com is always ready to ... tickets to many events. Cheap NHL hockey tickets are in ... , Hockey fans are enthusiastic about their sport, and they ... Now is the time to acquire 2014 NHL preseason tickets ... There will be a great deal of action and excitement, ...
(Date:8/20/2014)... often have difficulty falling asleep and staying asleep, and ... individuals with Alzheimer,s disease, this common and troubling symptom ... to nighttime confusion and wandering. , Now, a study ... (BIDMC) and the University of Toronto/Sunnybrook Health Sciences Center ... Reported online today in the journal Brain , ...
Breaking Medicine News(10 mins):Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 3Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2Health News:2014 NHL Preseason Tickets Are Among Top Selling Seats at Trusted Provider BuyCheapTicketsToEvents.com 2Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3
... Prize Announced to Recognize Outstanding Journalism in, Support of Parkinson,s Disease ... ... NEW YORK, May 9 Although the weatherman predicted rain,that did not ... on Saturday, April 26th to unite as a passionate and,dedicated community to ...
... Sunrise Senior Living,Inc. (NYSE: SRZ ), today announced ... at the 2008 Bank of America Healthcare,Conference in Las ... Pacific,Time., Sunrise will Web cast the presentation live ... http://www.sunriseseniorliving.com ). A,replay of the Web cast will be ...
... May 9 Claremont Insurance,Services ( http://www.claremontcompanies.com ... today announced an innovative partnership to,market and ... broker,channel. PayrollSelect expands the selling power and ... an additional recurring revenue,stream for the broker ...
... to have suffered from depression before the diagnosis, , , ... are more than twice as likely to develop post-traumatic ... anxiety disorders, new research suggests. , About 16 percent ... at the Ohio State University Medical experienced PTSD 18 ...
... Washington University School of Medicine in St. Louis working ... immune cells long thought to be responsible for type ... the immune cells from isolated insulin-making structures in the ... the immune cells, known as dendritic cells, "red-handed": carrying ...
... Force,Colonel Mike Turner, a Democratic candidate for U.S. Congress ... inspired by MSNBC host,Keith Olbermann. Today is the 169th ... key architect of Hillary Clinton,s,notorious 1993 health care plan, ... 10th District voters what, if any, plan she has ...
Cached Medicine News:Health News:14th Annual Parkinson's Unity Walk Most Successful Event to Date 2Health News:14th Annual Parkinson's Unity Walk Most Successful Event to Date 3Health News:New Payroll Service Expands Selling Power and Service Capability of Employee Benefits Brokers 2Health News:Mood Disorders Put Breast Cancer Patients at Risk for PTSD 2Health News:Suspected cause of type 1 diabetes caught 'red-handed' for the first time 2Health News:Suspected cause of type 1 diabetes caught 'red-handed' for the first time 3Health News:Mike Turner, Virginia Congressional Candidate, Starts Healthcare Countdown 2
Dynamic brace that provides a low load, prolonged stretch to the connective tissue around the joint using an adjustment hinge with a built-in tension spring...
... Original Knee Brace gives fracture treatment patients ... control, this brace features the the Bledsoe ... from 0-120, and positively locks at any ... eccentric cam slots, the Bledsoe Multi-Centric Hinge ...
The Bledsoe Adjustable Knee Brace is designed to meet the most stringent demands of post-op care. When post-op care demands the best, the Bledsoe Adjustable Knee Brace is the physicians' preferred ch...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: